These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3814528

  • 1. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases.
    Kerkhofs H, Hermans J, Haak HL, Leeksma CH.
    Br J Haematol; 1987 Jan; 65(1):73-81. PubMed ID: 3814528
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems.
    Rubio-Felix D, Giraldo P, Franco E, Gimeno J, Giralt M.
    Hematol Oncol; 1995 Jan; 13(3):139-52. PubMed ID: 7622144
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
    Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD.
    Blood; 1986 Jun; 67(6):1765-72. PubMed ID: 3708160
    [Abstract] [Full Text] [Related]

  • 8. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
    Rubio-Félix D, Franco E, Giraldo P, Gimeno J, Cuesta I, Giralt M.
    Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysis.
    Raymakers R, Preijers F, Boezeman J, Rutten E, De Witte T.
    Leuk Lymphoma; 1994 Jun; 14(1-2):111-20. PubMed ID: 7920217
    [Abstract] [Full Text] [Related]

  • 12. [Chromosome abnormalities in myelodysplastic syndrome].
    Fujita K, Mori H, Niikura H, Terada H, Shinohara T.
    Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic implications in myelodysplastic syndromes: A review of 62 cases.
    Higuchi T, Mori H, Niikura H, Omine M, Fujita K.
    Leuk Lymphoma; 1996 May; 21(5-6):479-84. PubMed ID: 9172814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W.
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [Abstract] [Full Text] [Related]

  • 18. Update on the prognostic implication of morphology, histology, and karyotype in primary myelodysplastic syndromes.
    Verhoef G, De Wolf-Peeters C, Kerim S, Van De Broeck J, Mecucci C, Van den Berghe H, Boogaerts M.
    Hematol Pathol; 1991 Jan; 5(4):163-75. PubMed ID: 1794966
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C, Acevedo S, Bengio R, Arrossagaray G, Watman N, Rossi N, García J, Flores G, Goldztein S, Larripa I.
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.